USA flag logo/image

An Official Website of the United States Government

EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) IS A TERM GIVEN TO A CLINICAL…

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
4985
Program Year/Program:
1986 / SBIR
Agency Tracking Number:
4985
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
Integrated Microsystems, Inc
2488 Antietam Drive Ann Arbor, MI 48105
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 1986
Title: EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) IS A TERM GIVEN TO A CLINICAL PROCEDURE USED TO PROVIDE RESPIRATORY SUPPORT FOR ILL NEONATES.
Agency: HHS
Contract: N/A
Award Amount: $50,000.00
 

Abstract:

EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) IS A TERM GIVEN TO A CLINICAL PROCEDURE USED TO PROVIDE RESPIRATORY SUPPORT FOR ILL NEONATES. THIS PROCEDURE REQUIRES ACCESS TO TWO SOURCES OF VENOUS BLOOD WHEN PERFORMING THE PROCEDURE AS VENO-VENOUS (VV) BY-PASS. BLOOD IS DRAINED FROM THE RIGHT ATRIUM VIA A CANNULA IN THE RIGHT JUGULAR VEIN, OXYGENATED BY A MEMBRANE LUNG AND RETURNED VIA THE FEMORAL VEIN. THE DRAWBACKS OF THIS TECHNIQUE ARE THE ADDED TIME FOR CANNULA- TION AND LOWER EXTREMITY VENOUS INSUFFICIENCY RESULTING FROMFEMORAL LIGATION. ADDITIONALLY, VV ECMO IS PREFERRED OVER VENO-ARTERIAL (VA) ECMO BECAUSE THE CAROTID ARTERY IS PRE- SERVED. THE PHASE I PROPOSAL IS FOR THE DESIGN AND ASSEMBLYOF A FLEXIBLE THIN-WALLED DOUBLE LUMEN CANNULA (DLC) SUITABLE FOR NEONATE APPLICATION. THE DLC OBTAINS ACCESS VIA THE JUGULAR VEIN TO THE RIGHT ATRIUM WHERE DRAINAGE AND PERFUSION OCCUR SIMULTANEOUSLY. EXPERIMENTS WERE CONDUCTED USING PROTOTYPE DLCS WITH RESULTS INDICATING THAT THE DLC CAN PROVIDE ADEQUATE SUPPORT AND HAS ADVANTAGES FOR USE OVERTHE TWO-CANNULA METHOD FOR VV OR VA ECMO. THE BENEFITS WILLBE DECREASED PATIENT MORBIDITY. PHASE II RESEARCH INCLUDES DEVELOPMENT AND HUMAN TESTING OF THE ECMO DLC TO PROVE SAFETY AND EFFICACY, WITH THE FINAL GOAL OF MAKING THE CANNULA COMMERCIALLY AVAILABLE.

Principal Investigator:

Kenneth l drake
PRINCIPAL INVESTIGATOR
3139945218

Business Contact:

Small Business Information at Submission:

Integrated Microsystems Inc
2488 Antietam Drive Ann Arbor, MI 48105

EIN/Tax ID:
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No